Sort   by:  
 Page size 
UnknownNon-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis.
Not available
S-EPMC4801815 | biostudies-literature
UnknownDeveloping a generic business case for an advanced chronic liver disease support service.
Not available
S-EPMC10935515 | biostudies-literature
UnknownOnce-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials.
Not available
S-EPMC7257245 | biostudies-literature
UnknownSingle-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.
Not available
S-EPMC7275457 | biostudies-literature
UnknownSingle-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD.
Not available
S-EPMC8149706 | biostudies-literature
UnknownInforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions.
Not available
S-EPMC8047616 | biostudies-literature
UnknownPolθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.
Not available
S-EPMC8211653 | biostudies-literature
UnknownGenomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis.
Not available
S-EPMC9646734 | biostudies-literature
Unknown'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England.
Not available
S-EPMC3585494 | biostudies-literature
UnknownSafety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Not available
S-EPMC7674972 | biostudies-literature
Sort   by:  
 Page size